- Home
- SNTI vs EXOZ Comparison
SNTI vs EXOZ Comparison
Compare SNTI & EXOZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- EXOZ
- Stock Information
- Founded
- SNTI 2016
- EXOZ 2014
- Country
- SNTI United States
- EXOZ United States
- Employees
- SNTI N/A
- EXOZ N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- EXOZ
- Sector
- SNTI Health Care
- EXOZ
- Exchange
- SNTI Nasdaq
- EXOZ NYSE
- Market Cap
- SNTI 85.3M
- EXOZ 89.8M
- IPO Year
- SNTI N/A
- EXOZ N/A
- Fundamental
- Price
- SNTI $3.10
- EXOZ $14.55
- Analyst Decision
- SNTI Strong Buy
- EXOZ
- Analyst Count
- SNTI 1
- EXOZ 0
- Target Price
- SNTI $12.00
- EXOZ N/A
- AVG Volume (30 Days)
- SNTI 225.5K
- EXOZ 13.7K
- Earning Date
- SNTI 05-06-2025
- EXOZ 05-12-2025
- Dividend Yield
- SNTI N/A
- EXOZ N/A
- EPS Growth
- SNTI N/A
- EXOZ N/A
- EPS
- SNTI N/A
- EXOZ N/A
- Revenue
- SNTI N/A
- EXOZ N/A
- Revenue This Year
- SNTI N/A
- EXOZ N/A
- Revenue Next Year
- SNTI N/A
- EXOZ N/A
- P/E Ratio
- SNTI N/A
- EXOZ N/A
- Revenue Growth
- SNTI N/A
- EXOZ N/A
- 52 Week Low
- SNTI $1.52
- EXOZ $8.50
- 52 Week High
- SNTI $16.94
- EXOZ $23.99
- Technical
- Relative Strength Index (RSI)
- SNTI 41.06
- EXOZ N/A
- Support Level
- SNTI $3.10
- EXOZ N/A
- Resistance Level
- SNTI $3.61
- EXOZ N/A
- Average True Range (ATR)
- SNTI 0.40
- EXOZ 0.00
- MACD
- SNTI -0.07
- EXOZ 0.00
- Stochastic Oscillator
- SNTI 9.50
- EXOZ 0.00
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About EXOZ EXOZYMES INC
EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods.